Subscribe

Chronic Phase CML Model for Predicting Complete Cytogenetic Response to Imatinib Mesylate

Purpose:

To determine the chances of having a complete cytogenetic response following imatinib mesylate therapy in a Philadelphia chrosome positive CML in chronic phase.

Specialty:

Hematology Oncology

Objective:

risk factors

ICD-10:

C92.1

Description:

Kantarjian et al developed a model for predicting the chances that a patient with Philadelphia-chromosome positive chronic myeloid leukemia (CML) in the chronic phase. The authors are from the MD Anderson Cancer Center at the University of Texas Houston.

To read more or access our algorithms and calculators, please log in or register.

RECENT TWEETS

medal descover
medal iphone